CD38 and neoplasm: Gene expression profiling of CD38+ and CD38− members of the same clone highlighted elevated levels of VEGF and Mcl-1 in CD38+ cells, conferring a survival advantage potentially from CD38-mediated interactions with the tumor microenvironment [65].